Art

J-GLOBAL ID：202002246006087430   Reference number：20A0559557

Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

神経栄養性受容体チロシンキナーゼ融合陽性進行性固形腫瘍の成人と小児の患者の診断およびトロポミオシン受容体キナーゼ阻害剤使用に関する日本小児血液学/腫瘍学会の協力による日本癌治療学会/日本臨床腫瘍学会主導の臨床勧告

Author (53)： Naito Yoichi (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Naito Yoichi (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Mishima Saori (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Mishima Saori (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Akagi Kiwamu (Saitama Cancer Center, Saitama, Japan) ,  Akagi Kiwamu (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Igarashi Ataru (Yokohama City University School of Medicine, Yokohama, Japan) ,  Igarashi Ataru (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Ikeda Masafumi (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Ikeda Masafumi (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Okano Susumu (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Okano Susumu (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Kato Shunsuke (Juntendo University, Tokyo, Japan) ,  Kato Shunsuke (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Takano Tadao (Tohoku University, Sendai, Japan) ,  Takano Tadao (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Tsuchihara Katsuya (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Tsuchihara Katsuya (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Terashima Keita (National Center for Child Health and Development, Tokyo, Japan) ,  Terashima Keita (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Nishihara Hiroshi (Keio University, Tokyo, Japan) ,  Nishihara Hiroshi (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Nishiyama Hiroyki (Tsukuba University, Ibaraki, Japan) ,  Nishiyama Hiroyki (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Hiyama Eiso (Hiroshima University Hospital, Hiroshima, Japan) ,  Hiyama Eiso (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Hirasawa Akira (Okayama University, Okayama, Japan) ,  Hirasawa Akira (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Hosoi Hajime (Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Hosoi Hajime (Hokkaido University Hospital, Sapporo, Japan) ,  Hosoi Hajime (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Maeda Osamu (Nagoya University Hospital, Nagoy, Japan) ,  Maeda Osamu (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Yatabe Yasushi (National Cancer Center Hospital, Tokyo, Japan) ,  Yatabe Yasushi (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Okamoto Wataru (Hiroshima University Hospital, Hiroshima, Japan) ,  Okamoto Wataru (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Ono Shigeru (Jichi Medical University, Tochigi, Japan) ,  Ono Shigeru (Japanese Society of Pediatric Hematology/Oncology (JSPHO), Tokyo, Japan) ,  Kajiyama Hiroaki (Nagoya University Hospital, Nagoy, Japan) ,  Kajiyama Hiroaki (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Nagashima Fumio (Kyorin University Faculty of Medicine, Tokyo, Japan) ,  Nagashima Fumio (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Hatanaka Yutaka (Hokkaido University Hospital, Sapporo, Japan) ,  Hatanaka Yutaka (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Miyachi Mitsuru (Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Miyachi Mitsuru (Hokkaido University Hospital, Sapporo, Japan) ,  Kodera Yasuhiro (Nagoya University Hospital, Nagoy, Japan) ,  Kodera Yasuhiro (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan) ,  Yoshino Takayuki (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Yoshino Takayuki (Japanese Society of Medical Oncology (JSMO), Tokyo, Japan) ,  Taniguchi Hiroya (Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan) ,  Taniguchi Hiroya (Japan Society of Clinical Oncology (JSCO), Tokyo, Japan)
Material： International Journal of Clinical Oncology (Web)
Volume： 25  Issue： 3  Page： 403-417  Publication year： 2020 
JST Material Number： U1599A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *receptor tyrosine kinase ,...
Semi thesaurus term： *NTRK ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0559557&from=J-GLOBAL&jstjournalNo=U1599A") }}

Author keywords (5)： Neurotrophic receptor tyrosine kinase (NTRK) fusion ,  Tropomyosin receptor kinase (TRK) inhibitor ,  Advanced solid tumor ,  Tumor-agnostic treatment ,  Clinical practice guideline

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (2)： Entrectinib ,  Larotrectinib

Terms in the title (19)： 神経 ,  栄養 ,  受容体チロシンキナーゼ ,  融合 ,  固形腫瘍 ,  成人 ,  小児 ,  患者の診断 ,  トロポミオシン ,  受容体キナーゼ ,  阻害剤 ,  日本 ,  小児血液学 ,  腫瘍 ,  学会 ,  協力 ,  臨床腫瘍学 ,  臨床 ,  勧告